by Judith Cassel | Dec 10, 2024 | News
Three of four states rejected legalization measures, and federal rescheduling remains uncertain by the Drug Enforcement Administration. by Julie A. Werner-SimonOmer Ilter December 9, 2024 The November 2024 election is behind us. Four states presented marijuana...
by Micah Bucy | Dec 4, 2024 | News
On Tuesday, the U.S. Department of Veterans Affairs announced that it committed to fund a $1.5 million dollar clinical trial to study the potential benefits of MDMA-assisted therapy for veterans suffering from PTSD and alcohol use disorder. The study will take place...
by Micah Bucy | Nov 26, 2024 | News
Last week cannabis proponents filed a motion with the ALJ assigned to oversee the rescheduling efforts claiming that DEA was biased and colluding with the leading opponent of the rescheduling effort, Smart Approaches to Marijuana (SAM). Yesterday, the DEA and SAM...
by Micah Bucy | Nov 21, 2024 | News
On November 18th, designated participants in support of rescheduling cannabis filed a motion to have the DEA disqualified from participating in the rescheduling process alleging that the DEA has been colluding with parties opposing rescheduling, specifically Smart...
by Judith Cassel | Nov 19, 2024 | News
US (MA): CCC approves license for first research facility in the Commonwealth The Massachusetts Cannabis Control Commission (Commission) on Thursday, November 14, approved the Commonwealth’s first Marijuana Research Facility final license, marking continued...
by Judith Cassel | Nov 13, 2024 | News
ASTM D37 Passes Standards for Cannabis Vape Ingredient Safety Based on Framework by True Terpenes Head of Research News provided by True Terpenes Nov 13, 2024, 08:00 ET Guide and Procedure Published to Promote Science-Based Standards and Help Protect Consumer Health...
717-703-0804
